Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

DR info

Clinical trials : 21 / Drugs : 22 - (DrugBank : 10) / Drug target genes : 4 - Drug target pathways : 32

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

2-[4-[(2-amino-5-methyl-4-OXO-1,6,7,8-tetrahydropteridin-6-YL)methylam INO]benzoyl]amino
   Zambon Group S.p.A
      2007   -   EUCTR2006-000614-21-AT   Austria;Hungary;Italy;United Kingdom
      2006   Phase 2   EUCTR2006-000614-21-SK   Austria;Hungary;Slovakia;United Kingdom
      2006   Phase 2   EUCTR2006-000614-21-HU   Austria;Hungary;Slovakia;United Kingdom
      2006   -   EUCTR2006-000614-21-GB   Austria;Hungary;Italy;United Kingdom
5-mthf
   Zambon Group S.p.A
      2007   -   EUCTR2006-000614-21-AT   Austria;Hungary;Italy;United Kingdom
      2006   Phase 2   EUCTR2006-000614-21-SK   Austria;Hungary;Slovakia;United Kingdom
      2006   Phase 2   EUCTR2006-000614-21-HU   Austria;Hungary;Slovakia;United Kingdom
      2006   -   EUCTR2006-000614-21-GB   Austria;Hungary;Italy;United Kingdom
Acetaminophen
   Hospital de Clinicas de Porto Alegre
      2022   Phase 1/Phase 2   NCT04015557   Brazil
ACN00177
   Aeglea Biotherapeutics, Inc.
      2020   Phase 1   EUCTR2019-004791-19-GB   United Kingdom
Betaine
   Assistance Publique - Hôpitaux de Paris
      2015   Phase 2   NCT02404337   France
Creatine
   University of British Columbia
      2024   -   NCT06495567   Canada
Cysteine
   Hamad Medical Corporation
      2024   -   NCT06622577   Qatar
Detoxifying agents FOR antineoplastic treatment
   ZAMBON GROUP
      2006   -   EUCTR2006-000614-21-IT   Austria;Hungary;Italy;United Kingdom
Dietary methionine tracer and protein intake
   University of British Columbia
      2024   -   NCT06495567   Canada
EPI-743
   Bambino Gesù Hospital and Research Institute
      2013   Phase 2   NCT01793090   Italy
Methylenetetrahydrofolate reductase (mthfr) deficiency
   Istanbul Medeniyet University
      2019   -   NCT04287881   Turkey
N-acetylcysteine
   Hospital de Clinicas de Porto Alegre
      2022   Phase 1/Phase 2   NCT04015557   Brazil
   McGill University Health Center
      2007   Phase 2   NCT00483314   Canada
PEG
   Zhengzhou Children's Hospital
      2022   Phase 4   ChiCTR2100054613   China
Pegtarviliase IV
   Aeglea Biotherapeutics
      2021   Phase 1/Phase 2   NCT05154890   Australia;United Kingdom;United States
Pegtarviliase SC
   Aeglea Biotherapeutics
      2021   Phase 1/Phase 2   NCT05154890   Australia;United Kingdom;United States
Pegtibatinase
   Travere Therapeutics, Inc.
      2024   Phase 3   NCT06431893   United States
      2023   Phase 3   NCT06247085   United States
      2019   Phase 1/Phase 2   NCT03406611   United States
PKU express plus
   Vitaflo International, Ltd
      2021   -   NCT05051657   United Kingdom
Prefolic
   Zambon Group S.p.A
      2007   -   EUCTR2006-000614-21-AT   Austria;Hungary;Italy;United Kingdom
      2006   Phase 2   EUCTR2006-000614-21-SK   Austria;Hungary;Slovakia;United Kingdom
      2006   Phase 2   EUCTR2006-000614-21-HU   Austria;Hungary;Slovakia;United Kingdom
      2006   -   EUCTR2006-000614-21-GB   Austria;Hungary;Italy;United Kingdom
Prefolic 15*30CPR gastror 15MG
   ZAMBON GROUP
      2006   -   EUCTR2006-000614-21-IT   Austria;Hungary;Italy;United Kingdom
Rhgh
   Zhengzhou Children's Hospital
      2022   Phase 4   ChiCTR2100054613   China
SYNB1353
   Synlogic
      2022   Phase 1   NCT05462132   United States
Taurine
   University of Colorado, Denver
      2010   Phase 1/Phase 2   NCT01192828   United States